[Chronic insomnia in the elderly: balancing innovation and caution].

Authors

Carole Touffic, Alexandra Malliou, Geoffroy Solelhac

Published in

Revue medicale suisse. Volume 22. Issue 981. Pages 1760-1764. Oct 28, 2026.

Abstract

Chronic insomnia is a major public health issue due to its impact on quality of life, cognition, fall risk, and morbidity-mortality. Its prevalence increases with age. Cognitive behavioral therapy for insomnia remains the first-line treatment recommended by health societies but is very difficult to access (only 1% in Switzerland). Pharmacological treatment remains a second-line option. Prolonged-release melatonin and daridorexant (a dual orexin receptor antagonist) are potential options for long-term therapy.

PMID:
42958977
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.